Sargent Investment Group LLC Purchases New Position in SPDR S&P Biotech ETF $XBI

Sargent Investment Group LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 4,670 shares of the exchange traded fund’s stock, valued at approximately $569,000.

A number of other hedge funds have also modified their holdings of the company. Dynamic Wealth Strategies LLC raised its position in shares of SPDR S&P Biotech ETF by 3.8% in the 4th quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock valued at $268,000 after acquiring an additional 80 shares during the period. Capital Investment Advisory Services LLC raised its position in shares of SPDR S&P Biotech ETF by 4.0% in the 4th quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after acquiring an additional 81 shares during the period. Commerce Bank raised its position in shares of SPDR S&P Biotech ETF by 2.8% in the 4th quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock valued at $397,000 after acquiring an additional 90 shares during the period. Compass Ion Advisors LLC raised its position in shares of SPDR S&P Biotech ETF by 2.6% in the 4th quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock valued at $474,000 after acquiring an additional 97 shares during the period. Finally, Moors & Cabot Inc. raised its position in shares of SPDR S&P Biotech ETF by 3.8% in the 3rd quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after acquiring an additional 100 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $136.40 on Tuesday. The company has a market capitalization of $8.70 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The firm’s 50 day simple moving average is $132.78 and its 200 day simple moving average is $127.28. SPDR S&P Biotech ETF has a fifty-two week low of $80.90 and a fifty-two week high of $139.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.